These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3737314)

  • 1. Megavitamins and hyperactivity.
    Rimland B
    Pediatrics; 1986 Aug; 78(2):374-5. PubMed ID: 3737314
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder.
    Cox R; Krupnick J; Bush N; Houpt A
    J Miss State Med Assoc; 2000 Aug; 41(8):690-2. PubMed ID: 10974795
    [No Abstract]   [Full Text] [Related]  

  • 3. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interview with Professor Kurt Baerlocher, St. Gallen. Hyperactive child -- does it depend on magnesium?].
    Baerlocher K
    MMW Fortschr Med; 2003 Oct; 145(42):65. PubMed ID: 14655452
    [No Abstract]   [Full Text] [Related]  

  • 5. Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
    Ghanizadeh A
    J Clin Psychopharmacol; 2008 Dec; 28(6):725-6. PubMed ID: 19011458
    [No Abstract]   [Full Text] [Related]  

  • 6. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD).
    Joshi K; Lad S; Kale M; Patwardhan B; Mahadik SP; Patni B; Chaudhary A; Bhave S; Pandit A
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):17-21. PubMed ID: 16314082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder.
    Hazell P
    J Paediatr Child Health; 2007; 43(1-2):19-24. PubMed ID: 17207050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of megavitamin therapy on children with attention deficit disorders.
    Haslam RH; Dalby JT; Rademaker AW
    Pediatrics; 1984 Jul; 74(1):103-11. PubMed ID: 6234505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 15. Adderall XR: long acting stimulant for single daily dosing.
    Sallee FR; Smirnoff AV
    Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the cure for brain disorders outside the brain?
    Hyman MA
    Altern Ther Health Med; 2007; 13(6):10-5. PubMed ID: 17985807
    [No Abstract]   [Full Text] [Related]  

  • 17. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents' beliefs and attributions.
    Johnston C; Seipp C; Hommersen P; Hoza B; Fine S
    Child Care Health Dev; 2005 Nov; 31(6):669-77. PubMed ID: 16207224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.
    Konofal E; Arnulf I; Lecendreux M; Mouren MC
    Pediatr Neurol; 2005 May; 32(5):350-1. PubMed ID: 15866437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.